Skip to main content

Valuation Comps

BLUEPRINT — every business spun up from the factory inherits this template. Instance data lives in .invisible/ventures/{slug}/finance/. Never hardcode a business name, currency, or specific comparable in this file.

Founders either over-ask (kill the round) or under-ask (leave money on the table). Valuation is the most contested number in any raise. This template triangulates from three sources: public comps, precedent transactions, and DCF cross-check. The goal is a defensible range, not a single number.

Business Alignment

QuestionAnswer
Venture name[instance: name]
Raise stagepre-seed / seed / Series A / token / M&A
Target valuation range$X – $Y
ConvictionHIGH / MEDIUM / LOW / NONE
Who owns this analysis?[valuation-analyst agent / fractional CFO]

Three Triangulation Sources

No single method is right. Cross-check across three.

MethodWhat it measuresWhen it leads
Public compsWhat the market pays for similar companies todayStage has public equivalents
Precedent transactionsWhat acquirers actually paidLate-stage, M&A context
DCF cross-checkWhat the business is worth based on future cash flowsAny stage — keeps the other two honest

Public Comps

List 5–10 public companies in the same business model. Not the same industry — the same shape of revenue.

CompanyRevenueRevenue multipleGrowth rateGross marginWhy comparable
[name]$x%%[model match reason]

Trim the tails: drop the highest and lowest 20% to get a defensible multiple range.

Precedent Transactions

Last 24 months. Acquisitions of companies at similar stage and model.

TargetAcquirerDeal sizeTarget revenueMultiple paidDate

Read the story: why did the acquirer pay this multiple? Distress sale, strategic fit, competitive bidding war, desperate buyer? The multiple carries context.

DCF Cross-Check

Build a 5-year projection with terminal value. Discount at stage-appropriate rate.

InputRangeNotes
5-year revenue forecast[from financial-modeler]Reconcile to pitch deck
Free cash flow margin[range]Exit margin assumption
Terminal growth rate2–3%Not the growth rate — the terminal
Discount rate15–30%Stage-adjusted (early stage higher)
Terminal multiple10–15x FCFOr industry median

DCF trap: wide ranges in early-stage assumptions produce wide valuations. Use DCF to sanity-check the other two methods, not to set price.

Pre/Post-Money Bridge

Line$
Pre-money valuation
New investment
Post-money valuation
New investor ownership %
Existing shareholders ownership %
Option pool expansion %
Effective founder dilution

409A (If Applicable)

For US-registered companies issuing employee options. Separate from fundraising valuation — typically 20–40% lower, reflecting common-stock discount.

ParameterNotes
409A provider[third party]
Fair market value of commonLower than preferred
Update frequencyEvery 12 months or after material event
Material eventsPrimary raise, acquisition offer, major customer loss

Sanity Checks

Before stating a number:

  • Three methods triangulate to an overlapping range
  • The bottom of the range still lets founders build the company (not forced to take a down round at plan)
  • The top of the range has real comparable support (not aspirational)
  • The multiple reflects growth rate — 30% growth ≠ 300% growth valuation
  • Counter-thesis stated: what would make this worth half?

Receipt

On completion, valuation-analyst writes a receipt to .invisible/context/receipts/ with:

  • factory_instance_id = parent factory
  • business_id = this venture slug
  • phase = finance
  • task_id = finance.5
  • Primary artefact = .invisible/ventures/{slug}/finance/valuation.md

Context

Questions

  • If all three methods disagree, which do you trust — and why?
  • What's the lowest valuation you'd accept, and what would you give up to protect the higher number?
  • Which comparable in your list is the one investors will push back on? Have you rehearsed the answer?